A subset of patients with B-NHL initially does not respond to chemo-immunotherapies or relapses and no longer responds to further treatments. Therefore, there is an urgent need to identify underlying resistance factors and develops new targeted therapies to revers resistance.
Overexpression of the Transcription Factor Yin Yang 1 in Non-Hodgkin Lymphoma is associated with Chemo-Immune Resistance
Falzone L;LIBRA, Massimo;
2016-01-01
Abstract
A subset of patients with B-NHL initially does not respond to chemo-immunotherapies or relapses and no longer responds to further treatments. Therefore, there is an urgent need to identify underlying resistance factors and develops new targeted therapies to revers resistance.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
